Published in Biochim Biophys Acta on December 06, 1979
A quantitative test for superoxide radicals produced in biological systems. Biochem J (1982) 1.22
Kinetic studies on the reduction of cytochrome c. Reaction with dihydroxy conjugated compounds (catechols and quinols). Biochem J (1982) 0.88
Synthetic and natural polyanions induce cytochrome c release from mitochondria in vitro and in situ. Am J Physiol Cell Physiol (2011) 0.79
Some electron-transfer reactions involving carbodi-imide-modified cytochrome c. Biochem J (1987) 0.78
Antihypertensive effect of mitochondria-targeted proxyl nitroxides. Redox Biol (2014) 0.77
Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid (1981) 4.07
Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun (2001) 2.67
Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation (1996) 2.31
Plasmid R6K DNA replication. III. Regulatory properties of the pi initiation protein. J Mol Biol (1982) 2.12
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem (1993) 1.72
Basic science of HER-2/neu: a review. Semin Oncol (1999) 1.70
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res (1999) 1.60
Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry (1999) 1.55
Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli. Proc Natl Acad Sci U S A (1981) 1.53
Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D Biol Crystallogr (2000) 1.47
Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol (2006) 1.46
Malignant melanoma in Turner's syndrome. Int J Dermatol (1993) 1.41
Reversible hepatic injury induced by long-term vitamin A ingestion. Am J Med (1992) 1.39
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine (1993) 1.32
Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun (2002) 1.26
Multiple low spin forms of the cytochrome c ferrihemochrome. EPR spectra of various eukaryotic and prokaryotic cytochromes c. J Biol Chem (1977) 1.25
Structural properties of the beta origin of replication of plasmid R6K. J Biol Chem (1983) 1.22
Evidence for P-N bond scission in phosphoroamidate nerve agent adducts of human acetylcholinesterase. Biochemistry (2000) 1.21
N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochem J (1993) 1.20
Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19
Spectroelectrochemical studies of the corrinoid/iron-sulfur protein involved in acetyl coenzyme A synthesis by Clostridium thermoaceticum. Biochemistry (1989) 1.17
Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem (1994) 1.14
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant (2001) 1.11
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun (2003) 1.11
The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. J Biol Chem (1991) 1.10
High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene (2000) 1.10
Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut (2007) 1.10
ColE1 DNA sequences interacting in cis, essential for mitomycin-C induced lethality. Mol Gen Genet (1979) 1.08
Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res (1997) 1.05
An outbreak of psittacosis in a boys' boarding school. J Hyg (Lond) (1984) 1.05
Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers. Biochemistry (1999) 1.05
Partial purification and characterization of a new intracellular beta-glucosidase of Trichoderma reesei. Biochem J (1980) 1.05
Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge. J Virol (1989) 1.04
Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center. FEBS Lett (1993) 1.04
Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase. J Biol Chem (1995) 1.03
Redox properties of several bacterial ferredoxins using square wave voltammetry. J Biol Chem (1990) 1.01
Purification and properties of a low-redox-potential tetraheme cytochrome c3 from Shewanella putrefaciens. J Bacteriol (1996) 1.00
Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels. Biochem J (1998) 1.00
The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors. J Biol Chem (1996) 1.00
Interrelations between assembly and secretion of recombinant human acetylcholinesterase. J Biol Chem (1993) 1.00
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infect Immun (2003) 1.00
Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry (1995) 1.00
Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochem J (1995) 0.99
Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology (1999) 0.99
The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis. J Biol Chem (1994) 0.99
Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem (1996) 0.98
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene (1998) 0.97
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. Eur J Cancer (2004) 0.97
Hepatitis C virus viremia in SCID-->BNX mouse chimera. J Infect Dis (1995) 0.96
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice. Br J Pharmacol (2011) 0.96
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin Cancer Res (1999) 0.96
Hepatitis B virus infection associated with hematopoietic tumors. Am J Pathol (1994) 0.96
A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Gastroenterology (2000) 0.96
Evaluation of anchorage-dependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells. Cytotechnology (1993) 0.95
Cleavage maps of a tetracycline plasmid from Staphylococcus aureus. J Bacteriol (1978) 0.94
Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem Res Toxicol (2001) 0.94
Identification and characterization of the functional alpha origin of DNA replication of the R6K plasmid and its relatedness to the R6K beta and gamma origins. Mol Gen Genet (1987) 0.94
Functional characteristics of the oxyanion hole in human acetylcholinesterase. J Biol Chem (1998) 0.93
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen. Infect Immun (2005) 0.93
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat (2008) 0.92
The changing pattern of glomerulonephritis in Singapore over the past two decades. Clin Nephrol (1999) 0.92
Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol (1998) 0.92
Separate intramolecular pathways for reduction and oxidation of cytochrome c in electron transport chain reactions. Proc Natl Acad Sci U S A (1973) 0.92
Effect of human acetylcholinesterase subunit assembly on its circulatory residence. Biochem J (2001) 0.90
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Biochem J (1998) 0.89
Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochem J (2001) 0.89
Assay of UDPG1cUA pyrophosphatase and its relation to transglucuronidation. Biochim Biophys Acta (1970) 0.89
Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma. Clin Cardiol (1996) 0.89
A DNA segment within the colicin E1 structural gene on ColE1 affecting immunity to colicin. Mol Gen Genet (1978) 0.88
Incompleteness of statutory notification of bacterial gastro-intestinal infection. Public Health (1997) 0.88
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine (2005) 0.87
Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase? Biochemistry (2001) 0.87
Transcription signals in a region essential for replication of plasmid R6K. Plasmid (1985) 0.87
Immunization against hepatitis B through adoptive transfer of immunity. Intervirology (1995) 0.87
Solution structure of the oxidized 2[4Fe-4S] ferredoxin from Clostridium pasteurianum. Eur J Biochem (1995) 0.87
Quality of sleep in the medical department. Br J Clin Pract (1992) 0.87
p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer (1995) 0.87
Suppressor cell function in mesangial IGA nephritis. Aust N Z J Med (1982) 0.87
Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase. Mol Pharmacol (1994) 0.86
ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int (2000) 0.86
Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects. J Biol Chem (1987) 0.86
A preliminary comparison of structural models for catalytic intermediates of acetylcholinesterase. Chem Biol Interact (1999) 0.86
Reversal of signal-mediated cellular retention by subunit assembly of human acetylcholinesterase. J Biol Chem (1994) 0.86
Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives. Mol Pharmacol (1996) 0.86
Parvovirus B19 outbreak on an adult ward. Epidemiol Infect (1994) 0.86
Reactions of the ferri-ferrocytochrome-c system with superoxide/oxygen and CO2-/CO2 studied by fast pulse radiolysis. Biochim Biophys Acta (1976) 0.85
Variation in the CD4+ and CD8+ populations in lymph nodes does not reflect that in the blood during SIVMNE/E11S infection of macaques. J Med Primatol (1992) 0.85
Bovine acetylcholinesterase: cloning, expression and characterization. Biochem J (1998) 0.85
A spectroelectrochemical cell designed for low temperature electron paramagnetic resonance titration of oxygen-sensitive proteins. Anal Biochem (1989) 0.84
Identification of the P1 compatibility and plasmid maintenance locus by a mini P1/ac+-plasmid. Virology (1979) 0.84
Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos. J Neurochem (1994) 0.84
Alpha and beta replication origins of plasmid R6K show similar distortions of the DNA helix in vivo. Proc Natl Acad Sci U S A (1990) 0.84
The study of 1-electron equivalent oxidation-reduction reactions by fast pulse generation of reagents. Cytochrome c/ferri-ferrocyanide system. J Biol Chem (1976) 0.84
Case series: hyponatremia associated with moderate exercise. Am J Med Sci (1996) 0.84
Characterization of the recombinant Clostridium pasteurianum ferredoxin and comparison of its properties with those of the native protein. Biofactors (1990) 0.84
Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration. Miner Electrolyte Metab (1982) 0.84